BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ducker C, Shaw PE. Ubiquitin-Mediated Control of ETS Transcription Factors: Roles in Cancer and Development. Int J Mol Sci 2021;22:5119. [PMID: 34066106 DOI: 10.3390/ijms22105119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wei Y, Han S, Wen J, Liao J, Liang J, Yu J, Chen X, Xiang S, Huang Z, Zhang B. E26 transformation-specific transcription variant 5 in development and cancer: modification, regulation and function. J Biomed Sci 2023;30:17. [PMID: 36872348 DOI: 10.1186/s12929-023-00909-3] [Reference Citation Analysis]
2 Ducker C, Ratnam M, Shaw PE, Layfield R. Comparative analysis of protein expression systems and PTM landscape in the study of transcription factor ELK-1. Protein Expr Purif 2023;203:106216. [PMID: 36528218 DOI: 10.1016/j.pep.2022.106216] [Reference Citation Analysis]
3 Wang Y, Huang Z, Sun M, Huang W, Xia L. ETS transcription factors: Multifaceted players from cancer progression to tumor immunity. Biochim Biophys Acta Rev Cancer 2023;1878:188872. [PMID: 36841365 DOI: 10.1016/j.bbcan.2023.188872] [Reference Citation Analysis]
4 Mahajan M, Sarkar A, Mondal S. Cell cycle protein BORA is associated with colorectal cancer progression by AURORA-PLK1 cascades: a bioinformatics analysis. J Cell Commun Signal 2022. [DOI: 10.1007/s12079-022-00719-6] [Reference Citation Analysis]
5 H.s. Richter G. Drug Targeting of Chromosomal Translocations in Fusion-Positive Sarcoma. Bone Tumors - Recent Updates [Working Title] 2022. [DOI: 10.5772/intechopen.106671] [Reference Citation Analysis]
6 Flores G, Grohar PJ. One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma. J Bone Oncol 2021;31:100404. [PMID: 34976713 DOI: 10.1016/j.jbo.2021.100404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]